TIENGO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 7.696
EU - Europa 731
AS - Asia 644
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 9.079
Nazione #
US - Stati Uniti d'America 7.693
CN - Cina 470
FI - Finlandia 191
SE - Svezia 181
VN - Vietnam 155
DE - Germania 122
UA - Ucraina 99
GB - Regno Unito 71
IT - Italia 30
FR - Francia 16
IN - India 15
IE - Irlanda 11
NL - Olanda 5
CA - Canada 3
EU - Europa 3
BE - Belgio 2
IR - Iran 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
EG - Egitto 1
JP - Giappone 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
Totale 9.079
Città #
Fairfield 1.323
Woodbridge 783
Chandler 670
Houston 634
Jacksonville 583
Ann Arbor 483
Wilmington 482
Ashburn 474
Seattle 471
Cambridge 459
Princeton 201
Dong Ket 155
Roxbury 123
San Diego 123
Beijing 113
Nanjing 93
Guangzhou 66
Helsinki 65
Des Moines 64
Medford 62
Boardman 57
Shenyang 34
Hebei 30
Nanchang 26
Norwalk 26
Shanghai 26
Jiaxing 20
Changsha 15
New York 13
Dublin 11
Tianjin 11
Redwood City 10
London 8
Dearborn 7
Ogden 7
Hefei 6
Jinan 6
Borås 5
Kharkiv 5
Padova 5
Rome 5
Tappahannock 5
Kilburn 4
Chiswick 3
Hounslow 3
Indiana 3
Los Angeles 3
Rockville 3
Washington 3
Ardabil 2
Boulder 2
Chicago 2
Fuzhou 2
Groningen 2
New Bedfont 2
Ningbo 2
Paris 2
Prescot 2
Pune 2
San Francisco 2
Wandsworth 2
Auckland 1
Augusta 1
Barnet 1
Bologna 1
Brentford 1
Brussels 1
Catania 1
Edmonton 1
Falls Church 1
Freiburg 1
Gouvieux 1
Hangzhou 1
Hendon 1
Huzhou 1
Islington 1
Jinhua 1
Kunming 1
Lanzhou 1
Lima 1
Manchester 1
Milan 1
Mons 1
Munich 1
Nanning 1
Nuremberg 1
Okotoks 1
Pinehaven 1
Simi Valley 1
Sofia 1
Southwark 1
Sumusta al Waqf 1
Taizhou 1
Wageningen 1
Xian 1
Yellow Springs 1
Yerevan 1
Zhengzhou 1
Totale 7.848
Nome #
EFFECTS OF CHRONIC ALCOHOL INTAKE ON CARBOHYDRATE AND LIPID-METABOLISM IN SUBJECTS WITH TYPE-II (NON-INSULIN-DEPENDENT) DIABETES 142
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 128
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 127
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 122
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 119
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 118
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 115
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 113
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects 109
Endothelial progenitor cells and the diabetic paradox. 109
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. 105
Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis. 105
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 105
Mechanisms of acute and chronic hypoglycemic action of gliclazide 105
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects 100
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 100
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 100
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients 99
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver 97
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 96
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. 96
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 95
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 93
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 92
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 91
Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin 90
Hepatic lipid metabolism and non-alcoholic fatty liver disease. 90
The metabolic syndrome, diabetes and lung dysfunction. 90
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. 90
The use of degrees of certainty to evaluate knowledge 89
Non esterified fatty acids and endothelial dysfunction 88
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. 88
Continuous subcutaneous insulin infusion (CSII) in Italy 87
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients 86
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes 85
Continuous subcutaneous glucose monitoring in diabetic patients - A multicenter analysis 84
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 84
Regulation of postprandial whole-body proteolysis in insulin-deprived IDDM. 83
The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans 83
Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus 82
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 82
Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. 82
The effect of continuous subcutaneous insulin infusion treatment on proliferative diabetic retinopathy. 82
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 82
Relationship between plasma leucine concentration and clearance in normal and type 1 diabetic subjects. 81
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 81
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. 81
Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: A low molecular weight factor possibly involved 81
Early myocardial dysfunction in the diabetic heart: Current research and clinical applications 80
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 80
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia 79
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus 78
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 77
Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects 77
First isolation of Burkholderia cepacia from a deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen. 77
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. 77
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 76
Role of anti-granulocyte Fab ' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results 76
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. 74
Glucose tolerance is negatively associated with circulating progenitor cell levels. 74
Dose-response curves of effects of insulin on leucine kinetics in humans. 74
Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition 72
Effect of different times of administration of a single ethanol dose on insulin action, insulin secretion and redox state. 72
Sequelae of acute hypoglycaemia on 24 hour blood pressure and metabolic parameters in normal and type 1 (insulin-dependent) diabetic individuals. 72
Glucose tolerance during moderate alcohol intake: Insights on insulin action from glucose/lactate dynamics 72
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 72
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 72
In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 71
The metabolic syndrome, diabetes and lungdysfunction. 71
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment 71
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 71
The effects of oral amino acid intake on ambulatory capacity in elderly subjects 70
Model of the kinetics of ketone bodies in humans. 70
Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: The Cornell voltage 70
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations 70
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 69
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients 68
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. 68
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 66
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 66
Ketone body metabolism in normal and diabetic human skeletal muscle. 65
Circulating progenitor cells in the natural history of type 2 diabetes mellitus 64
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 64
PROTEIN METABOLISM IN GLUCAGONOMA. 63
Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients. 63
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. 63
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine 63
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels. 62
Role of intra-arterial calcium injection test and venous sampling (IACI) as localizing procedure in insulinomas. 61
Characteristics and mortality oftype 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia. 59
Extreme but asymptomatic hypergastrinemia with gastroparesis in a young woman with insulin dependent diabetes mellitus. 59
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 57
Alcohol impairs insulin sensitivity in normal subjects. 56
Accuracy of continuous subcutaneous glucose monitoring in detecting hypoglycemia in diabetic patients 55
Continuous glucose monitoring in conditions other than diabetes 55
Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action. 54
Visceral obesity is characterized by impaired nitric oxide-independent vasodilation 54
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 53
Oral amino acids in elderly subjects: Effect on myocardial function and walking capacity 52
INTRA-ARTERIAL CALCIUM INJECTION TEST AS LOCALIZING PROCEDURE IN INSULINOMAS. 51
Totale 8.137
Categoria #
all - tutte 28.890
article - articoli 26.031
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 363
Totale 55.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019705 0 0 0 0 0 0 0 0 0 0 375 330
2019/20202.091 358 56 38 120 216 178 213 242 209 200 131 130
2020/20211.551 65 130 23 135 87 164 39 142 230 118 186 232
2021/20221.633 23 191 219 109 64 120 74 162 98 25 200 348
2022/20231.319 248 142 9 179 206 174 1 110 171 7 57 15
2023/2024383 18 87 56 38 30 32 16 9 16 80 1 0
Totale 9.084